Location History:
- San Francisco, CA (US) (1998 - 2004)
- Daly City, CA (US) (2005 - 2012)
Company Filing History:
15 out of 15,488 
2 out of 832,891 Years Active: 1998-2012
Title: **Michael S German: Innovator in Diabetes Research**
Introduction
Michael S German is a renowned inventor based in San Francisco, CA, recognized for his significant contributions in the field of diabetes research. With an impressive portfolio of 17 patents, he has been instrumental in advancing medical technologies aimed at providing solutions for diabetes mellitus.
Latest Patents
Among his recent innovations are two notable patents centered on the production of pancreatic islet cells and insulin delivery. The first patent, titled "Polynucleotides comprising Neurogenin3 promoter and bHLH encoding domains," focuses on polypeptides exhibiting the activity of human neurogenin3 (hNgn3). This invention outlines the use of islet transcription factors like hNgn3 to aid in the production of pancreatic islet cells from progenitor cells, potentially enhancing insulin delivery through the resultant islet cells.
The second patent emphasizes methods for the production of islet cells and the expression of islet transcription factors in the pancreas. It introduces methods to encourage the expression of nucleic acids encoding neurogenin3 or factors inducing its expression, with the goal of producing new β-cells to treat patients suffering from diabetes mellitus.
Career Highlights
Throughout his career, Michael S German has had affiliations with distinguished institutions, notably the University of California. His extensive work in diabetes research has led to groundbreaking advancements, further solidifying his reputation as a leading inventor in the medical field.
Collaborations
German has collaborated with esteemed colleagues Ira D Goldfine and Stephen S Rothman, which has undoubtedly enhanced the innovative capacities and impact of his work. These partnerships reflect the collaborative nature of scientific research, particularly in developing solutions for complex health challenges like diabetes.
Conclusion
Michael S German's work continues to impact the landscape of diabetes treatment. With his numerous patents and collaborative efforts, he remains a pivotal figure in the quest for optimal strategies in insulin delivery and pancreatic cell production. His dedication to innovation is not only noteworthy, but also inspiring for future inventors and researchers in the field.